SCHEMBL3372687

SCHEMBL3372687

CCOC(=O)C(Cc1ccc(OCCc2nc(-c3ccc(OC)cc3)sc2C)c(C)c1)OCC

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 15/20 0.46
PPARA Q07869 14/20 0.46
PTPN11 Q06124 1/20 0.43
PPARD Q03181 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3371570 0.93 PPARG (0.50) PPARGPPARAPPARD
SCHEMBL3374198 0.91 PPARG (0.45) PPARGPPARAPTPN11PPARD
SCHEMBL3374455 0.90 PPARG (0.49) PPARGPPARAPPARD
SCHEMBL3374173 0.90 PPARG (0.46) PPARGPPARAPPARD
SCHEMBL3374331 0.89 PPARG (0.41) PPARGPPARAPPARD
SCHEMBL3373906 0.87 MAPT (0.43) PPARGPPARAPPARD
SCHEMBL3368823 0.86 PPARG (0.50) PPARGPPARAPTPN11
SCHEMBL3369286 0.84 PPARG (0.49) PPARGPPARAPPARD
SCHEMBL3375387 0.84 PPARA (0.40) PPARGPPARAPPARD
SCHEMBL3371149 0.84 PPARA (0.40) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537091-B1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS HOFFMANN LA ROCHE (CH) 2010-10-06 EP disclosed
EP-1537091-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2005-06-08 EP disclosed
US-6809110-B2 NONINSULIN DEPENDENT DIABETES; SUCH AS 2-ETHOXY-3-(4-(2-(5-METHYL-2-PHENYL-THIAZOL-4-YL)-ETHOXY)-BENZO(B)THIOPHEN-7-YL)-PROPIONIC ACID HOFFMANN-LA ROCHE INC. 2004-10-26 US disclosed
WO-2004020420-A1 NOVEL 2-ARYLTHIAZOLE COMPOUNDS AS PPARALPHA AND PPARGAMA AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2004-03-11 WO disclosed